Bio

Douglas Gray is Chair of Locke Lord's Life Sciences Practice Group, focusing on medical device, pharmaceutical and health care-related companies and products. He brings to his clients a broad range of experience in the practice of corporate law, concentrating in the areas of mergers and acquisitions, corporate governance, strategic alliances and commercial ventures. In addition, he enjoys an active collaborations practice, centered on negotiating licensing, joint venture and development agreements relating to intellectual property rights. Douglas is a member of the Firm's Board of Directors and Co-Chairs the Firm's Pro Bono Committee. Douglas' work in acquisitions, dispositions, joint ventures and other transactions involves representation of individual investors, management teams, corporate buyers and sellers, venture capitalists and private equity firms. This varied representation provides him with a unique understanding of the likely concerns of each party in a sophisticated transaction so that he is well-suited to assist clients in planning and implementing their strategies as well as crafting creative, but cost-effective, solutions to their concerns.